D-0515-2016 Class II Terminated
FDA drug recall D-0515-2016 was initiated by RemedyRepack Inc. on Nov 11, 2015 and is designated Class II. Reason for recall: Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions. The recall status is terminated (terminated Nov 1, 2016). Affected quantity: 1625 Vials.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 16, 2015
- Initiation Date
- Nov 11, 2015
- Termination Date
- Nov 1, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1625 Vials
Product description
Lorazepam 2 mg/mL Inj., Qty: 1 mL Vial, MFG by: West-Ward Pharma, Eatontown, NJ 07724, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0316-01
Reason for recall
Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Distribution pattern
Nationwide
Code information
LOT#: B0085124-051915, B0086919-052815, Exp 12/01/2016; B0089280-061215, B0090023-061915, B0089996-061915, B0091581-070715, B0091564-070715, B0091515-070715, Exp 01/01/2017; B0094980-080415, B0094965-080415, B0097515-082415, B0100639-091415, B0100611-091415, Exp 03/01/2017; B0100933-091515, B0107165-101915, B0107118-101915, Exp 06/01/2017.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0515-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026